WuXi AppTec Co Ltd
SSE:603259
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
36.87
90.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
WuXi AppTec Co Ltd
Intrinsic Value
WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. [ Read More ]
The intrinsic value of one
WuXi AppTec Co Ltd
stock under the Base Case scenario is
89.79
CNY.
Compared to the current market price of 39.54 CNY,
WuXi AppTec Co Ltd
is
Undervalued by 56%.
WuXi AppTec Co Ltd's market capitalization is 117.4B CNY.
WuXi AppTec Co Ltd stock price is 39.54 CNY.
WuXi AppTec Co Ltd stock price (39.54 CNY) is 56% less than its Intrinsic Value (89.79 CNY).
WuXi AppTec Co Ltd stock price (39.54 CNY) is 45% less than its DCF Value (71.76 CNY). Open DCF Valuation
WuXi AppTec Co Ltd stock price (39.54 CNY) is 63% less than its Relative Value (107.82 CNY). Open Relative Valuation
WuXi AppTec Co Ltd has upside potential of 87% compared to the average analyst price target.
Open Wall St Estimates
WuXi AppTec Co Ltd's Revenue has dropped by 1% over the past 12 months.
WuXi AppTec Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 14% to 18%.
WuXi AppTec Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 15%.
WuXi AppTec Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 11% to 15%.
WuXi AppTec Co Ltd has positive Free Cash Flow for the last twelve months.
WuXi AppTec Co Ltd's Revenue is forecast to grow at a rate of 8% per year over the next 3 years.
WuXi AppTec Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 18%.
WuXi AppTec Co Ltd has positive three-year average ROIC (Return on Invested Capital): 14%. The company is efficient at using invested capital to generate operating income.
WuXi AppTec Co Ltd has positive Net Income for the last twelve months.
WuXi AppTec Co Ltd has positive Operating Income for the last twelve months.
WuXi AppTec Co Ltd has positive three-year average ROE (Return on Equity): 18%. The company is efficient at transforming stockholders' equity into net income.
WuXi AppTec Co Ltd has positive Gross Profit for the last twelve months.
WuXi AppTec Co Ltd's Revenue has been growing by an exceptional 29% per year for the last 3 years.
WuXi AppTec Co Ltd's short-term assets (30B CNY) exceed its short-term liabilties (15B CNY).
WuXi AppTec Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (10B CNY) than debt (5B CNY).
WuXi AppTec Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.1.
WuXi AppTec Co Ltd's long-term assets (74B CNY) exceed its long-term liabilties (19B CNY).
WuXi AppTec Co Ltd's Altman Z-Score is very high and is equal to 6.12.
Valuation Backtest
WuXi AppTec Co Ltd
Run backtest to discover the historical profit from buying and selling
WuXi AppTec Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
WuXi AppTec Co Ltd
| Current Assets | 30.4B |
| Cash & Short-Term Investments | 10B |
| Receivables | 10.4B |
| Other Current Assets | 10B |
| Non-Current Assets | 43.2B |
| Long-Term Investments | 10.8B |
| PP&E | 26.6B |
| Intangibles | 3.7B |
| Other Non-Current Assets | 2.1B |
| Current Liabilities | 14.8B |
| Accounts Payable | 1.6B |
| Accrued Liabilities | 3.2B |
| Short-Term Debt | 3.7B |
| Other Current Liabilities | 6.3B |
| Non-Current Liabilities | 3.8B |
| Long-Term Debt | 1.8B |
| Other Non-Current Liabilities | 2B |
Earnings Waterfall
WuXi AppTec Co Ltd
|
Revenue
|
39.4B
CNY
|
|
Cost of Revenue
|
-23.6B
CNY
|
|
Gross Profit
|
15.8B
CNY
|
|
Operating Expenses
|
-4.8B
CNY
|
|
Operating Income
|
10.9B
CNY
|
|
Other Expenses
|
-1.6B
CNY
|
|
Net Income
|
9.4B
CNY
|
Free Cash Flow Analysis
WuXi AppTec Co Ltd
| CNY | |
| Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
WuXi AppTec Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
WuXi AppTec Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
WuXi AppTec Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
WuXi AppTec Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
WuXi AppTec Co Ltd
According to Wall Street analysts, the average 1-year price target for
WuXi AppTec Co Ltd
is 73.87 CNY
with a low forecast of 36.87 CNY and a high forecast of 134.4 CNY.
Click here to dive deeper.
Price Appreciation
Price
WuXi AppTec Co Ltd
| Average Annual Return | 29.55% |
| Standard Deviation of Annual Returns | 59.66% |
| Max Drawdown | -78% |
| Market Capitalization | 117.4B CNY |
| Shares Outstanding | 2 933 327 890 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
WuXi AppTec Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 34,912 full-time employees. The company went IPO on 2018-05-08. WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The firm is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The firm mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.
Contact
IPO
Employees
Officers
The intrinsic value of one
WuXi AppTec Co Ltd
stock under the Base Case scenario is
89.79
CNY.
Compared to the current market price of 39.54 CNY,
WuXi AppTec Co Ltd
is
Undervalued by 56%.
You don't have any saved screeners yet
